Jul 30th, 2024
2 mins
The British Society for Allergy and Clinical Immunology (BSACI) has published new guidelines for using Palforzia®, a treatment that helps children with peanut allergies build tolerance safely. This treatment aims to reduce the severity of allergic reactions in case of accidental exposure to peanuts, and therefore reduce the risk of anaphylaxis.
Peanut allergy is one of the most common food allergies among children and is often a lifelong condition. Palforzia® works by gradually introducing small amounts of peanut protein to help them build tolerance and reduce severe allergic reactions. The treatment involves multiple visits to increase the dose, careful monitoring, and eventually transitioning to eating peanuts daily in a real-world setting.
You can read more, and access a link to the guidelines, on the Anaphylaxis UK website here
